now owns 10,000 shares of the company, valued at approximately $600,000. **Key Takeaways:**
* **Consolidated Portfolio Review Corp. (CPR) acquired a new position in MetLife, Inc. (MET) during the second quarter.**
* **CPR’s investment in MET was valued at approximately $290,000.**
* **Other hedge funds and institutional investors have also made changes to their holdings of MET.**
* **Gilbert & Cook Inc.
This follows a similar move by Morgan Stanley, which raised its price target for MetLife to $85.00 from $80.00 and maintained a “buy” rating. These analyst upgrades are significant because they reflect a positive outlook on the insurance giant’s future prospects. **Key Points:**
* **Analyst Upgrades:** Several brokerages have recently upgraded their price targets and ratings for MetLife. * **Positive Outlook:** These upgrades indicate a positive outlook on MetLife’s future prospects.
MetLife’s financial performance has been mixed in recent months. While the company has reported consistent earnings per share, recent growth in revenue has been slower than anticipated. This suggests that the company may be facing some challenges in a competitive market, particularly in its life insurance business.
**Here are some key points about MetLife’s dividend:**
* **Type of dividend:** The dividend is a regular dividend, meaning it is paid on a recurring basis, not a special dividend. * **Dividend amount:** The dividend amount is $0.545 per share. * **Ex-dividend date:** The ex-dividend date is Tuesday, August 6th. This means that shareholders who sell their shares before this date will not be entitled to the dividend. * **Payment date:** The dividend payment date is Tuesday, September 10th.
news is a contributor at Roll Pet. We are committed to providing well-researched, accurate, and valuable content to our readers.
